VYNE vs EVOK
Comparison between VYNE Therapeutics Inc (VYNE, Company) and Evoke Pharma Inc (EVOK, Company).
Both VYNE and EVOK are from the Healthcare sector.
VYNE vs EVOK - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
VYNE
$19M
EVOK
$19M
Max Drawdown
VYNE
N/A
EVOK
99.90%
Sharpe Ratio
VYNE
0.00
Winner
EVOK
1.02
5Y Beta
VYNE
0.00
EVOK
N/A
Industry
VYNE
Biotechnology
EVOK
Drug Manufacturers - Specialty & Generic
P/E Ratio
VYNE
-0.33
Winner
EVOK
-3.23
5Y EPS CAGR
VYNE
-58.49%
Winner
EVOK
-45.26%
Debt to Equity
VYNE
0.00%
EVOK
0.00%
Free Cash Flow Yield
VYNE
N/A
EVOK
-17.55%
VYNE vs EVOK - Historical Returns
Returns include dividend reinvestment.
1M
VYNE
N/A
EVOK
+2.90%
3M
VYNE
N/A
EVOK
+116.11%
6M
VYNE
N/A
EVOK
+296.40%
1Y
VYNE
N/A
EVOK
+139.65%
5Y(CAGR)
VYNE
N/A
EVOK
-52.20%
10Y(CAGR)
VYNE
N/A
EVOK
-31.29%
Max(CAGR)
Winner
VYNE
+124759277.90%
EVOK
-33.75%
VYNE vs EVOK - Annual Returns (2013 - 2026)
Returns include dividend reinvestment.
| Year | VYNE | EVOK |
|---|---|---|
| 2026 | +12.22% | N/A |
| 2025 | N/A | +146.09% |
| 2024 | N/A | -64.24% |
| 2023 | N/A | -61.10% |
| 2022 | N/A | -62.30% |
| 2021 | N/A | -79.63% |
| 2020 | N/A | +61.25% |
| 2019 | N/A | -36.47% |
| 2018 | N/A | +5.53% |
| 2017 | N/A | +9.18% |
| 2016 | N/A | -38.04% |
| 2015 | N/A | -45.36% |
| 2014 | N/A | -23.48% |
| 2013 | N/A | -36.54% |
VYNE vs EVOK Drawdown Comparison
The maximum drawdown for EVOK was -99.90%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current EVOK drawdown is -99.45%.
| Rank | VYNE | EVOK |
|---|---|---|
| #1 | N/A | -99.90% Oct 4, 2013 - Apr 8, 2025 |
| #2 | N/A | -0.66% Sep 30, 2013 - Oct 3, 2013 |
| #3 | N/A | -0.34% Sep 25, 2013 - Sep 27, 2013 |
Correlation
Correlation between VYNE and EVOK is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: VYNE vs SPYEVOK vs SPY
More Comparisons
Compare with similar stocks